spacer
home > ict > Winter 2008
PUBLICATIONS

International Clinical Trials

ict
Winter 2008
At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. ICT provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in this issue of ICT
   
Text
PDF
bullet
Clinical Trial Management
As the pharma industry struggles to cope with the high rate of Phase III failures, Mike Macnamee of LCG Bioscience believes that it is crucial to use patients in the early stages of clinical research in order to grasp the opportunities created by more personalised and gene-specific therapeutics, in Patients Are a Virtue  
view
download pdf
Kenneth Getz at the Tufts Center for the Study of Drug Development, James Kremidas at Eli Lilly and Company, Elizabeth Carfioli of Ogilvy Healthworld Consulting (US) and Rachael Butlin at Fast4wD Ogilvy (UK) pursue ways in which to challenge and improve public perceptions of clinical research, in We Can be Heroes  
view
download pdf
In New Waves, Dr Timothy Callahan and Dr Pierre Maison-Blanche of Biomedical Systems put the spotlight on comprehensive training at investigative sites – a necessary step for ensuring that ECG data collected onsite is of a high quality, free of artifact and has minimal variability  
view
download pdf
Bruce Stouch at Premier Research explores the construct of asymmetrical boundaries for interim monitoring of a fixed design, as well as the design requirements for monitoring using a Bayesian approach, in Monitored Progress  
view
download pdf
bullet
eCLINICAL
Secure, private and of higher quality than paper diary records, eDiaries have finally entered the mainstream. In Regulating e-Diaries, Valdo Arnera and Stephen A Raymond of PHT Corporation reflect on the key regulations affecting eDiary systems and how their providers and sponsors should adhere to these rules  
view
download pdf
In Pharma Champion, Mark Penniston at Omnicare Clinical Research General notes that acceptance of CDISC has gained momentum over the past few years and has a very strong future, especially as regulatory bodies increase their usage of these standards  
view
download pdf
Clinical trials frequently rely on subjective clinician-rated outcomes as pivotal endpoints – thus missing out on electronic tools which can assist in reinforcing continuous data reliability. In Improving Ratings Precision, Oto Markovic and Rusty Bealer of United BioSource Corporation examine how these systems can be designed and deployed in support of clinical trials  
view
download pdf
bullet
Drug delivery & Therapeutics
Over the past year revenues from global clinical trials have increased by almost 15 per cent. Gary Muddyman of Conversis unpicks the Cultural Dimensions of running trials in emerging markets, outlining the need to avoid stumbling blocks such as differing clinical trial demands in disparate locales, varied sales and distribution channels, the coordination of simultaneous launches to market, and drug cloning and counterfeiting  
view
download pdf
Having overcome a recent spot of trouble, Russia’s role in the development of international clinical trials in Central and Eastern Europe looks increasingly promising; whilst the emergence of Ukraine, Belarus and Kazakhstan in the trials arena in 2008 will be one to watch out for, opines Irina Dobreva of Congenix in Research Reaches Beyond Borders  
view
download pdf
Shifting pharmacovigilance and clinical data management work abroad is allowing pharmaceutical firms to maximise R&D and push drugs to market more effectively – Charles Arnold and Vicki Tauscher Phelan of EquaTerra investigate The New Frontier in outsourcing  
view
download pdf
bullet
Labs & Logistics
In The Power of Communication, Mark Woolf of Almac Clinical Services explores the complex challenges faced by distribution managers surrounding the shipping of clinical trials materials to emerging markets  
view
download pdf
The temperature-sensitive nature of numerous drugs and the importance of achieving reliable test results make it particularly important that drugs arrive at their destination with their integrity intact. Geraint Thomas of Laminar Medica points to the advantages of careful planning and investment in the latest technology during shipping, in The Trials of Temperature Control  
view
download pdf
   
spacer
Edited by
Dr Graham Hughes
Consultant in
Pharmaceutical
Development

Published quarterly in
February, May,
August and November

News and Press Releases

Wickham Laboratories will be on Stand 8 at the 24th Annual Pharmig Conference in the Nottingham Belfry Hotel, November 16th & 17th


More info >>

White Papers

Overcoming research challenges with Adaptive Trials

PCI Pharma Services

There has been cause for concern within the pharmaceutical industry over the last five years, regarding increasing research and development costs, combined with a fall in the number of new drugs brought to market. In an attempt to overcome this issue there has been a significant rise in the use of adaptive clinical trial designs, whilst saving time and money as well as facilitating more effective decision making. One of the biggest challenges that pharmaceutical companies have experienced has been delivering compliant clinical trials supplies across diverse patient populations in the relatively short timeframes that adaptive trial designs require, remaining focused on ensuring that patient compliance and product quality is in no way compromised. This demand has led to the launch of fast response services that support Research and Development in responding to changing dosing regimens mid-trial.
More info >>

Industry Events

BioPharm America™ 2017—10th Annual International Partnering Conference

26-27 September 2017, 39 Dalton Street, Boston, MA 02116

BioPharm America™ is a unique partnering event that forms the nexus of discovery and realization. Startup companies, established biotech and entrepreneurs from academia attend in search of finance, pharma and development partners.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement